L. reuteri DSM 17648

£34.99 or £33.24 / month

L. reuteri DSM 17648
  • Natural, and no fillers or additives
  • Binds specific stomach bacteria
  • Pure, safe and clean PyloPass™
  • 5 white papers to show effectiveness against stomach bacteria
  • Vegan capsules
  • 30 day supply (120 capsules)
  • Only £1.15 per daily dosage
Product highlights
  • Binds to specific stomach bacteria and removes via natural bowel movement
  • Contains safe, clean and clinically proven PyloPass™ no additives or fillers
  • Used to reduce and remove specific stomach bacteria
  • 100mg of PyloPass™ per capsule
  • 30 day supply
Recommended for

To bind and remove specific stomach bacteria which is passed out via your natural bowel movement.

  • Specific stomach bacteria
  • Recurring acid caused by stomach bacteria
  • Histamine released by stomach bacteria
Ingredients

Each capsule contains PyloPass™ – 5 billion CFU Lactobacillus Reuteri DSM 17648 (inactivated), maize dextrin and hydroxypropyl-methylcellulose (capsule shell).

Pure, clean and safe to use for the long term.

How to use

Take 1-2 capsules twice per day with 200ml liquid immediately before or during solid meals.

Use this product daily for 3 months according to the recommendation for use. We recommend using the L. reuteri DSM 17648 (PyloPass) with Toxaprevent Medi Plus Sachets.

Disclaimer: Food supplements should not be used as a substitute for a varied diet. Do not exceed the recommended daily dose. Keep out of reach of children. Pregnant women and children should use the product under medical supervision.

Key benefits of Pylopass
  • Used to reduce symptoms caused by the specific stomach bacteria
  • Binds, removes and detoxes stomach bacteria and the bacterial load
  • Targets only the stomach bacteria
  • Not absorbed by the body simply binds to stomach bacteria
  • Not processed by the body
  • Simply detoxes the stomach bacteria from the body through natural bowel movement
Where the capsules work:

The L. reuteri DSM 17648 (Pylopass™) has only one purpose: to target, reduce and remove the specific stomach bacteria and the overall bacteria load from the stomach.

L. reuteri DSM 17648 (Pylopass™) is a clinically researched and effective inactivated bacteria strain which targets specific stomach bacteria. The L. reuteri DSM 17648 (Pylopass™) targets the specific stomach bacteria to reduce the overall bacteria load on the body and the symptoms associated with the stomach bacteria.

The L. reuteri DSM 17648 (Pylopass™) contains inactivated cells of a specific strain of L. reuteri, and is put through a special and unique spray drying process. This ensures that the L. reuteri DSM 17648 does not require refrigeration and can survive harsh acidic stomach acid without breaking down.

L. reuteri DSM 17648 has a long history of safe use within the food chain. Lactobacillus reuteri is included in the European Food Safety Associations (EFSA) list of microorganisms for Qualified Presumption of Safety (QPS). QPS status implies that the specific strain has not been associated with safety issues and can therefore be safely consumed by adults and children from 4 years and above.

What the capsules do

The L. reuteri DSM 17648 (Pylopass™) has only one purpose: to target, reduce and remove the specific stomach bacteria and reduce the bacterial load on the body.

L. reuteri DSM 17648 (Pylopass™) is a clinically researched and effective inactivated bacteria strain which targets specific stomach bacteria. The L. reuteri DSM 17648 (Pylopass™) targets the specific stomach bacteria to reduce the overall bacteria load on the body and the symptoms associated with the stomach bacteria.

The L. reuteri DSM 17648 (Pylopass™) contains inactivated cells of a specific strain of L. reuteri, and is put through a special and unique spray drying process. This ensures that the L. reuteri DSM 17648 does not require refrigeration and can survive harsh acidic stomach acid without breaking down.

What is Pylopass™?

Pylopass™ contains inactivated cells of a specific strain of L. reuteri, and is put through a special and unique spray drying process. This ensures that the L. reuteri DSM 17648 does not require refrigeration and can survive harsh acidic stomach acid without breaking down.

L. reuteri DSM 17648 (Pylopass™) is a clinically researched and effective inactivated bacteria strain that targets specific stomach bacteria. The L. reuteri DSM 17648 (Pylopass™) targets the specific stomach bacteria to reduce the overall bacteria load on the body and the symptoms associated with the stomach bacteria.

Pylopass™ is a registered trademark and product designed by the scientific team at Novozymes GmbH.

(1 customer review)

Available on back-order

Purchase this product now and earn up to 34 Health Points.

Choose a purchase plan:

Free UK Delivery
Free Worldwide Tracked Shipping on orders over £250

1 review for L. reuteri DSM 17648

  1. Jennifer Nyhuis

    I used the L.reuteri alongside the 5 day Toxaprevent protocol. I have a very persistent stomach bacteria. I felt amazing while on it! My systemic inflammation seemed to disappear! I specifically noticed, during the protocol, that I was able to bound down my stairs in the morning with no achy stiffness. Quite a noticeable difference from my regular morning feel!

Add a review

FAQs

L. reuteri DSM 17648

L. Reuteri DSM 17648 has a long history of safe use within the food chain. Lactobacillus reuteri is included in the European Food Safety Associations (EFSA) list of microorganisms for Qualified Presumption of Safety (QPS). QPS status implies that the specific strain has not been associated with safety issues. It can therefore be safely consumed by adults and children from 4 years and above.

L. Reuteri DSM 17648 does not contain any harmful substances or ingredients which bear potential risks (according EU regulation 1169/2011). L. Reuteri DSM 17648 is free from allergens:

cereals with gluten (wheat, rye, barley, oats, spelt, kamut or hybridized strain) and products thereof, shellfish and, eggs and products thereof, fish and products thereof, peanuts and products thereof, soya and products thereof, milk and products thereof (including lactose), nuts (almond, walnut, cashew nut, pecan nut, brazil nut, pistachio, macademia nut queensland nut) and products thereof, celery and products thereof, lupins and products thereof, molluscs and products thereof, mustard and products thereof, sesame seeds and products thereof, sulphur dioxide and sulphites > 10 ppm), genetically modified organisms (GMOs), nanomaterials, polycyclic aromatic hydrocarbons, pesticides and doping substances and is BSE/TSE-free

Lactobacillus reuteri DSM 17648 does not originate from, nor employ substrates of, animal origin during any part of its manufacture. Statements concerning these substances are available on request.

L. Reuteri DSM 17648 exhibits glycoproteins on its surface which recognise and bind to glycoproteins exhibited from specific bacteria that reside in the stomach. These structures are unique to this strain of L. reuteri.

Other strains of L. reuteri and probiotics are usually intended to reach the gut where they can multiply and colonise in order to promote healthy gut bacteria. However, L. Reuteri DSM 17648 is an inactivated (i.e. dead) strain of L. reuteri which is not intended to colonise in the gut. Instead, it is intended to bind to specific gut bacteria, after which, L. Reuteri DSM 17648 and the gut bacteria bound to it will travel through the digestive tract where they will be eliminated through natural bowel movements.

Once the bacterium is bound to by L. Reuteri DSM 17648, it simply travels through the gastrointestinal tract and passes out via natural bowel movement.

L. Reuteri DSM 17648 contains a patented strain of Lactobacillus reuteri (DSM 17648) which, in studies, has shown to specifically binds and co-aggregate to specific bacteria that resides in the stomach. Thanks to this unique mode of action this has allowed L. Reuteri DSM 17648 to give the body a natural way of fighting the bacteria, supporting a healthy stomach environment and good gastric function.

Previous

Next